Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT07400458

Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration

Sponsor: Pharmicell Co., Ltd.

View on ClinicalTrials.gov

Summary

This Long-term follow-up is designed to evaluate the safety of patient with Acute Myocardial Infarction who had administered Hearticellgram-AMI.

Official title: Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration to Evaluate Its Safety in Patients With Acute Myocardial Infarction

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2022-03-03

Completion Date

2032-09-30

Last Updated

2026-02-10

Healthy Volunteers

Conditions

Acute Myocardial Infarction

Interventions

BIOLOGICAL

Hearticellgram-AMI

Patients who had administered Hearticellgram-AMI.

Locations (1)

KIMHYUNSOO Clinic

Seoul, Gangnam, South Korea